From April 22 to 23, from north to south and from China to Africa, Dier took action to advance the field of clinical microbiology.

On April 23, the Microbiology Academic Conference of Jiamusi City, Heilongjiang Province, co-organized by De’er, was held in Jiamusi.

On April 23, the Sichuan Province Antimicrobial Resistance Surveillance Conference, co-organized by Dier, was held in Chengdu.

On April 23, the Jiangxi Province Shangrao City Microbiology Academic Conference, co-organized by Deere, was held in Shangrao.

On April 23, Dier showcased its latest microbial diagnostic products at the Anhui Provincial Clinical Laboratory Conference for promotional purposes.

On April 23, Dier showcased its latest microbial diagnostic products at the Shaanxi Provincial Clinical Conference for promotional purposes.

On April 23, De’er attended the Guangdong Provincial Medical Association’s Laboratory Medicine Symposium held in Zhuhai.

On April 22, Dier’s African distributor presented the company’s microbial diagnostic products to experts and educators at Mediconex, Africa’s largest medical exhibition, held in Cairo, Egypt.

This is a day worth commemorating for the Dier people.

The clinical microbiology laboratory is the weakest link in most hospital laboratories and represents a major bottleneck to their development. It faces the contradiction between the need for rapid result reporting in clinical diagnosis and the time‑consuming nature of conventional microbial culture; the tension between the requirement for independent financial accountability and the persistently high costs of imported microbiological equipment and consumables; the clash between national policies aimed at curbing the overuse of antibiotics and the longstanding practice of empiric prescribing by clinicians, coupled with a hospital‑centric model that relies on drug revenue to sustain operations; the dilemma of grassroots hospitals seeking cutting‑edge microbiological diagnostic technologies and products while grappling with insufficient staffing and limited expertise in microbiology; and, indeed, many other challenges as well.

As a leader in the clinical microbiology diagnostics industry, Dier is acutely aware of the responsibility we bear. We are committed to advancing the field of clinical microbiology—not only by providing frontline hospital microbiologists with a robust platform and supportive environment for professional development, but also by boosting sales of Dier products and strengthening recognition of the Dier brand. Together with the nation, we are working to curb the inappropriate use of antibiotics; alongside academic researchers, we are driving the growth of hospital microbiology laboratories and the broader national microbiology enterprise; and in partnership with you, we are rising to meet the challenges facing clinical microbiology.